Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31.
| Autor: | Nabid A; Radiation Oncology, Centre Hospitaler Universitaire de Sherbrooke, Sherbrooke, Canada. Electronic address: abdenour.nabid@usherbrooke.ca., Souhami L; McGill University Health Centre, Montreal, Canada. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | European urology [Eur Urol] 2019 Mar; Vol. 75 (3), pp. e63. Date of Electronic Publication: 2018 Oct 26. |
| DOI: | 10.1016/j.eururo.2018.10.029 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect